T1	DISO 55 72	sepsis nosocomial
#1	AnnotatorNotes T1	C1096454; Nosocomially acquired neonatal sepsis; Disease or Syndrome
T2	CHEM 86 96	cefazolina
#2	AnnotatorNotes T2	C0007546; cefazolin; Organic Chemical · Antibiotic
T3	CHEM 99 110	vancomicina
#3	AnnotatorNotes T3	C0042313; vancomycin; Amino Acid, Peptide, or Protein · Antibiotic
T4	PROC 112 164	estudio de no inferioridad, aleatorizado, controlado
#4	AnnotatorNotes T4	C4505128; Non-Inferiority Trial; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity
T5	DISO 170 194	infecciones nosocomiales
#5	AnnotatorNotes T5	C0010356; Cross Infection; Disease or Syndrome | C0205721; Infections, Hospital; Disease or Syndrome
T6	PROC 340 359	evaluar la eficacia
#6	AnnotatorNotes T6	C1707887; Efficacy Study; Research Activity
T7	CHEM 366 376	cefazolina
#7	AnnotatorNotes T7	C0007546; cefazolin; Organic Chemical · Antibiotic
T8	CHEM 389 400	vancomicina
#8	AnnotatorNotes T8	C0042313; vancomycin; Amino Acid, Peptide, or Protein · Antibiotic
T9	PROC 406 413	terapia
#9	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	DISO 448 463	signos clínicos
#10	AnnotatorNotes T10	C0037088; Signs and Symptoms; Sign or Symptom
T11	DISO 479 496	sepsis nosocomial
#11	AnnotatorNotes T11	C1096454; Nosocomially acquired neonatal sepsis; Disease or Syndrome
T12	PROC 538 547	coagulasa
#12	AnnotatorNotes T12	C0201122; Coagulase test; Laboratory Procedure
T13	PROC 697 721	asignados aleatoriamente
#13	AnnotatorNotes T13	C0034656; Randomization; Research Activity
T14	PROC 597 611	hospitalizados
#14	AnnotatorNotes T14	C0019993; Hospitalization; Health Care Activity
T15	DISO 616 631	signos clínicos
#15	AnnotatorNotes T15	C0037088; Signs and Symptoms; Sign or Symptom
T16	DISO 649 677	sepsis bacteriana nosocomial
T17	PROC 770 781	tratamiento
#16	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T18	CHEM 789 799	cefazolina
#17	AnnotatorNotes T18	C0007546; cefazolin; Organic Chemical · Antibiotic
T19	CHEM 813 824	vancomicina
#18	AnnotatorNotes T19	C0042313; vancomycin; Amino Acid, Peptide, or Protein · Antibiotic
T20	PROC 834 899	análisis primario se realizó mediante la intención de tratamiento
T21	PROC 1004 1015	tratamiento
#19	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	DISO 1480 1497	sepsis nosocomial
#20	AnnotatorNotes T22	C1096454; Nosocomially acquired neonatal sepsis; Disease or Syndrome
T23	CHEM 1534 1544	cefazolina
#21	AnnotatorNotes T23	C0007546; cefazolin; Organic Chemical · Antibiotic
T24	CHEM 1566 1577	vancomicina
#22	AnnotatorNotes T24	C0042313; vancomycin; Amino Acid, Peptide, or Protein · Antibiotic
T25	PROC 73 81	tratados
#23	AnnotatorNotes T25	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T26	LIVB 22 36	recién nacidos
#24	AnnotatorNotes T26	C0021289; Infant, Newborn; Age Group
T27	CHEM 304 316	antibióticos
#25	AnnotatorNotes T27	C0003232; Antibiotics; Antibiotic
T28	LIVB 429 443	recién nacidos
#26	AnnotatorNotes T28	C0021289; Infant, Newborn; Age Group
T29	LIVB 582 596	recién nacidos
#27	AnnotatorNotes T29	C0021289; Infant, Newborn; Age Group
T30	CHEM 731 742	antibiótico
#28	AnnotatorNotes T30	C0003232; Antibiotics; Antibiotic
T31	LIVB 966 974	neonatos
#29	AnnotatorNotes T31	C0021289; Infant, Newborn; Age Group
T32	LIVB 1048 1062	recién nacidos
#30	AnnotatorNotes T32	C0021289; Infant, Newborn; Age Group
T33	LIVB 1171 1185	recién nacidos
#31	AnnotatorNotes T33	C0021289; Infant, Newborn; Age Group
T34	DISO 1345 1356	fallecieron
#32	AnnotatorNotes T34	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T35	LIVB 1359 1373	recién nacidos
#33	AnnotatorNotes T35	C0021289; Infant, Newborn; Age Group
T36	LIVB 1461 1475	recién nacidos
#34	AnnotatorNotes T36	C0021289; Infant, Newborn; Age Group
T41	Spec_cue 497 510	probablemente
T42	LIVB 523 556	Staphylococcus coagulasa negativo
#35	AnnotatorNotes T42	C0445625; Staphylococcus, coagulase negative; Bacterium
T45	Spec_cue 636 645	probables
T46	LIVB 656 666	bacteriana
#36	AnnotatorNotes T46	C0004611; Bacteria; Bacterium
T59	Spec_cue 1521 1529	probable
T37	Spec_cue 41 54	presunción de
T38	Spec_cue 464 478	presuntivos de
A1	Assertion T1 Speculated
A2	Assertion T11 Speculated
A3	Assertion T42 Speculated
A4	Assertion T16 Speculated
A5	Assertion T22 Speculated
A6	Population_data T26 Age
A7	Population_data T28 Age
A8	Population_data T29 Age
A9	Population_data T31 Age
A10	Population_data T32 Age
A12	Population_data T33 Age
A13	Population_data T35 Age
A14	Population_data T36 Age
T39	CONC 1406 1416	diferencia
#37	AnnotatorNotes T39	C1705241; Delta (difference); Quantitative Concept
T40	Neg_cue 1417 1419	no
T43	Quantifier_or_Qualifier 1420 1433	significativa
A16	Assertion T43 Negated
#38	AnnotatorNotes T43	C0750502; Significant; Idea or Concept
R1	Has_Quantifier_or_Qualifier Arg1:T39 Arg2:T43	
R2	Negation Arg1:T40 Arg2:T43	
T44	CONC 1310 1322	inferioridad
A17	Assertion T44 Negated
T47	Neg_cue 1307 1309	no
R3	Negation Arg1:T47 Arg2:T44	
T48	Neg_cue 1545 1547	no
T49	Quantifier_or_Qualifier 1552 1560	inferior
A18	Assertion T49 Negated
R4	Negation Arg1:T48 Arg2:T49	
T50	CONC 126 138	inferioridad
A19	Assertion T50 Negated
T51	Neg_cue 123 125	no
R5	Negation Arg1:T51 Arg2:T50	
T52	CONC 759 781	inicio del tratamiento
R6	Overlap Arg1:T30 Arg2:T52	
R7	Used_for Arg1:T30 Arg2:T17	
R8	Before Arg1:T13 Arg2:T17	
R9	Before Arg1:T13 Arg2:T18	
R10	Before Arg1:T13 Arg2:T19	
R11	Used_for Arg1:T18 Arg2:T17	
R12	Used_for Arg1:T19 Arg2:T17	
R13	Speculation Arg1:T37 Arg2:T1	
R14	Speculation Arg1:T38 Arg2:T11	
R15	Speculation Arg1:T41 Arg2:T42	
R16	Speculation Arg1:T45 Arg2:T16	
R17	Speculation Arg1:T59 Arg2:T22	
T53	CONC 1 18	Evolución clínica
#39	AnnotatorNotes T53	C0449259; Clinical course; Temporal Concept
R18	Experiences Arg1:T26 Arg2:T1	
R19	Experiences Arg1:T26 Arg2:T25	
R20	Used_for Arg1:T2 Arg2:T25	
R21	Used_for Arg1:T3 Arg2:T25	
R22	Used_for Arg1:T8 Arg2:T9	
R23	Used_for Arg1:T7 Arg2:T9	
T54	Quantifier_or_Qualifier 414 421	inicial
#40	AnnotatorNotes T54	C0205265; Initially; Temporal Concept
R24	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T54	
R25	Experiences Arg1:T28 Arg2:T7	
R26	Experiences Arg1:T28 Arg2:T10	
R27	Experiences Arg1:T28 Arg2:T11	
R28	Overlap Arg1:T10 Arg2:T11	
R29	Causes Arg1:T42 Arg2:T11	
T55	Result_or_Value 548 556	negativo
#41	AnnotatorNotes T55	C0205160; Negative; Finding
R30	Has_Result_or_Value Arg1:T12 Arg2:T55	
R31	Experiences Arg1:T28 Arg2:T12	
R32	Experiences Arg1:T28 Arg2:T55	
R33	Experiences Arg1:T29 Arg2:T14	
R34	Experiences Arg1:T29 Arg2:T15	
R35	Overlap Arg1:T15 Arg2:T16	
R36	Causes Arg1:T46 Arg2:T16	
T56	CONC 941 958	evolución clínica
#42	AnnotatorNotes T56	C0449259; Clinical course; Temporal Concept
T57	CONC 994 1015	final del tratamiento
R37	Overlap Arg1:T56 Arg2:T57	
R38	Experiences Arg1:T31 Arg2:T21	
T58	CONC 1095 1118	características basales
#43	AnnotatorNotes T58	C4684572; Baseline Characteristics; Qualitative Concept
T60	CONC 1190 1207	evolución clínica
#44	AnnotatorNotes T60	C0449259; Clinical course; Temporal Concept
R39	Experiences Arg1:T35 Arg2:T34	
R40	Experiences Arg1:T36 Arg2:T22	
R41	Experiences Arg1:T36 Arg2:T23	
R42	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T49	
R43	Experiences Arg1:T36 Arg2:T24	
T61	Observation 1596 1622	resultado clínico adecuado
#45	AnnotatorNotes T61	C1333602; Favorable Clinical Outcome; Finding (?)
R44	Causes Arg1:T23 Arg2:T61	
R45	Causes Arg1:T24 Arg2:T61	
R46	Experiences Arg1:T36 Arg2:T61	
#46	AnnotatorNotes T20	C2718028; Intention to Treat Analysis; Research Activity (?)
#47	AnnotatorNotes T49	C1550463; Observation Interpretation - worse; Idea or Concept
A11	Experiencer T26 Patient
A15	Experiencer T28 Patient
A20	Experiencer T29 Patient
A21	Experiencer T31 Patient
A22	Experiencer T32 Patient
A23	Experiencer T33 Patient
A24	Experiencer T35 Patient
A25	Experiencer T36 Patient
